Trials / Completed
CompletedNCT00396175
Effects of Finasteride on Serum Prostate-Specific Antigen (0906-111)
A Double-Blind, Placebo-Controlled, Multicenter Study To Examine the Effects of Finasteride 1 MG on Serum Prostate-Specific Antigen in Men With Androgenetic Alopecia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 355 (planned)
- Sponsor
- Organon and Co · Industry
- Sex
- Male
- Age
- 40 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
A clinical study to collect additional data in order to characterize the reduction in PSA with finasteride 1 mg, and its reversibility in men with androgenetic alopecia between the ages of 40 to 60 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0906, finasteride / Duration of Treatment : 48 Weeks | |
| DRUG | Comparator : placebo (unspecified) / Duration of Treatment : 48 Weeks |
Timeline
- Start date
- 1998-03-01
- Primary completion
- 2000-01-01
- First posted
- 2006-11-06
- Last updated
- 2022-02-17
Source: ClinicalTrials.gov record NCT00396175. Inclusion in this directory is not an endorsement.